Cemtrex Inc. is a world leading industrial and manufacturing solutions company. Cemtrex provides a broad mix Overview
Cemtrex Inc. is a world leading industrial and manufacturing solutions company. Cemtrex provides a broad mix of products and services for an array of industries in both foreign and domestic markets. The company manufactures custom circuit boards, emissions monitors, and environmental control and air filtration systems for the automotive, medical, refining, power, chemical and utilities industry, among others. Through their ROB Cemtrex division, they also provide contract electronic manufacturing services to original equipment manufacturers (OEM's).
This past Friday shares of Vivint Solar (VSLR 3.74) bounced off the bottom and rose 42% to 3.74. This occurred after the shares were upgraded by Deutsche Bank and gave it a price target of $7.50. The shares are down from a 52 week high of $16.00. Deutsche Bank believes that the shares are trading at a discount to valuation and operating assets.
Vuzix Corporation (VUZI 4.90) Update
Vuzix reported Q1 results Thursday after the closing bell and held the company’s Q1 conference call on Friday the 13th. The Friday the 13th conference call was anything but a nightmare and the positive message delivered by management to investors was resounding. Investor sentiment has been resoundingly positive and shares may be ready to take off beginning this week.
On May 4th, Synacor announced a partnership with AT&T worth upwards of $100 million a year upon full deployment. Syncacor held the company's Q1 conference call on May 10th and provided some color behind the AT&T win, expected revenue and investment related to the contract.
Synacor helps customers deliver relevant content to their consumers across all devices. Synacor's content reaches 120 million monthly visitors, 120 service providers, 3500 enterprises, 500 million email boxes and more than 1000 web publishers. Synacor delivers modern, multiscreen experiences and advertising to consumers through a B2B2C business model.
The star of the show at last week’s annual Game Developers Conference in San Francisco, attended by a record-setting crowd of 27,000, was Virtual Reality (VR). According to the Wall Street Journal, investors have already pumped $1.1 billion into augmented and virtual-reality companies this year—more than the total for any prior year—with researchers at Gartner Inc. estimating that nearly 40 million VR headsets will be sold worldwide by 2020.
Based in San Diego, CA, Mitek Systems, Inc. (NASDAQ:MITK), develops and markets mobile capture and identity solutions for customer acquisition. Their technology is licensed by more than 4,100 organizations and used by tens of millions of consumers. In June, 2015, Mitek acquired IDchecker, a global provider of cloud based identity document verification and facial recognition solutions.
When we last brought your attention to MITK shares in November, 2015, the company was firing on all cylinders, having reported record Q4 revenue of $7.9 million, up 42% year-over-year. Net EPS also increased to a record $0.03 per share, and cash flow jumped to $1.9 million, a $2.1 million year-over-year rise.
Fresh investment from Chinese Internet concern Tencent Holdings, Ltd.
Strong sales growth
High profile deal with pop music superstar Taylor Swift
Impending launch of popular Chinese title in U.S.
In October, 2015, FST was pounding the table on shares of Glu Mobile (NASDAQ: GLUU),a leading global developer and publisher of free-to-play games for smartphone and tablet devices. The company already had a series of successful and original products in that huge marketplace, including titles like BLOOD & GLORY: IMMORTALS, DEER HUNTER, DINER DASH, and TAP SPORTS BASEBALL. The company also develops branded games such as KIM KARDASHIAN: HOLLYWOOD, ROBOCOP: THE OFFICIAL GAME, and HERCULES: THE OFFICIAL GAME.
Every few years it seems like a new and exotic viral threat emerges, energizing buying interest in publically traded stocks of companies developing products to address the problem. Most recently, the rapidly spreading and highly dangerous Zika virus has been on traders’ radar, sending shares of Chembio Diagnostics, Inc., to a 52-week zenith Friday—driven higher by news that the company had been awarded a grant from philanthropist and entrepreneur Paul G. Allen to immediately initiate development of simple, cost-effective POC diagnostic tests to identify the Zika virus and related febrile illnesses.